ERBB2 and breast cancer: Xie et al. [68] employed multiparametric MR imaging and whole-tumour histogram analysis to distinguish triple-negative breast cancer from other subtypes of breast cancer and demonstrated good accuracy in the differential diagnosis of triple-negative breast cancer from Luminal A and HER2-enriched subtypes.